H&H International (SEHK:1112) Return To Profitability Challenges Longstanding Bearish Earnings Narratives

Health and Happiness (H&H) International Holdings (SEHK:1112) has reported FY 2025 first half revenue of C¥7.0b and basic EPS of C¥0.11, with the trailing twelve months showing revenue of C¥14.4b and basic EPS of C¥0.31 as profitability returned over the year. The company has seen revenue move from C¥6.7b in 1H 2024 to C¥7.0b in 1H 2025, while basic EPS shifted from C¥0.48 in 1H 2024 to C¥0.11 in 1H 2025. This sets up a results season in which investors will be weighing the earnings rebound against how durable those margins look.

See our full analysis for Health and Happiness (H&H) International Holdings.

With the headline numbers on the table, the next step is to weigh them against the most common narratives about H&H's growth, risks, and profitability to see which views hold up and which need a rethink.

Curious how numbers become stories that shape markets? Explore Community Narratives

TTM revenue at ¥14.4b with 6.6% annual growth

• Over the trailing twelve months, H&H generated ¥14.4b of revenue, which aligns with the 6.6% annual growth rate that sits below the 8.2% Hong Kong market benchmark.
• Supporting a more bullish view is the fact that this 6.6% revenue growth comes alongside a move from a ¥53.7m TTM loss in 2H 2024 to a ¥196.1m TTM profit in FY 2025. Anyone arguing the business is only growing modestly on the top line has to weigh that against the clear shift into positive net income.

Profit swings, but TTM EPS now ¥0.31

• At the half year level, net income moved from a ¥359.5m loss in 2H 2024 to a ¥71.0m profit in 1H 2025. On a trailing basis, Basic EPS is now ¥0.31, compared with a prior trailing period that still showed a small loss and EPS of ¥0.08.
• Skeptics often focus on the five year earnings decline of 42.3% per year. That concern about sustained weakness sits alongside TTM numbers that now show ¥196.1m of profit and positive EPS, which indicates recent profitability is not only coming from a single half year but from a full trailing period back in the black.

P/E of 36.1x with mixed valuation signals

• On the latest figures, H&H trades at a 36.1x trailing P/E versus a 56.7x peer average and a 12.8x Hong Kong Food industry average. The share price of HK$12.45 sits well below both the HK$17.30 analyst target level and the HK$73.70 DCF fair value in the data.
• Consensus narrative notes strong upside potential. The combination of an analyst target above the current HK$12.45 price and a DCF fair value of HK$73.70 strongly supports that bullish case, yet the weaker interest coverage highlighted in the risk summary means that investors who focus on balance sheet strength can point to a clear tension between valuation upside signals and the fact that current earnings are not described as comfortably covering interest expense.

Curious how that valuation gap and the return to profitability fit into the wider story for H&H, including what other investors are focusing on right now? 📊 Read the what the Community is saying about Health and Happiness (H&H) International Holdings.

Next Steps

Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Health and Happiness (H&H) International Holdings's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.

Given the mix of positive signals and ongoing concerns around H&H, it makes sense to move quickly, review the underlying data, and weigh both sides for yourself with the help of the 4 key rewards and 1 important warning sign.

See What Else Is Out There

The company is wrestling with a sharp drop in half year EPS, weaker long term earnings trends, and valuation signals that sit alongside interest coverage concerns.

If those profit swings and balance sheet questions leave you cautious, compare this situation with companies highlighted in the 283 resilient stocks with low risk scores to find ideas with steadier risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com